- Home
- BXSL vs CORT Comparison
BXSL vs CORT Comparison
Compare BXSL & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BXSL | CORT |
|---|---|---|
| Founded | 2018 | 1998 |
| Country | United States | United States |
| Employees | N/A | 500 |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 8.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BXSL | CORT |
|---|---|---|
| Price | $27.54 | $81.52 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 6 |
| Target Price | $29.38 | ★ $130.20 |
| AVG Volume (30 Days) | ★ 1.5M | 890.8K |
| Earning Date | 11-10-2025 | 11-04-2025 |
| Dividend Yield | ★ 11.20% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.66 | 0.87 |
| Revenue | ★ $1,413,784,000.00 | $741,172,000.00 |
| Revenue This Year | $9.05 | $23.79 |
| Revenue Next Year | $0.28 | $40.97 |
| P/E Ratio | ★ $10.35 | $93.35 |
| Revenue Growth | 10.58 | ★ 17.92 |
| 52 Week Low | $24.85 | $49.00 |
| 52 Week High | $34.64 | $117.33 |
Technical Indicators
Market Signals| Indicator | BXSL | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 48.00 | 50.45 |
| Support Level | $28.03 | $78.07 |
| Resistance Level | $28.59 | $83.37 |
| Average True Range (ATR) | 0.42 | 3.36 |
| MACD | -0.10 | -0.47 |
| Stochastic Oscillator | 18.57 | 31.98 |
Price Performance
Historical ComparisonAbout BXSL Blackstone Secured Lending Fund of Beneficial Interest
Blackstone Secured Lending Fund is a non-diversified, closed-end management investment company. The investment objectives of the company are to generate current income and, to a lesser extent, long-term capital appreciation. The company seeks to achieve its investment objectives by investing in originated loans and other securities, including syndicated loans of private U.S. companies, typically in the form of first lien senior secured and unitranche loans, unsecured and subordinated loans, and other securities.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.